Apexigen is a clinical-stage biopharmaceutical company discovering and developing a new generation of antibody therapeutics for the treatment of cancer with an emphasis on new immuno-oncology products.
Total raised: $216M
Investors 8
Funding Rounds 3
| Date | Series | Amount | Investors |
| 24.03.2020 | Series C | $123M | - |
| 08.08.2018 | Series B | $73M | - |
| 08.08.2013 | Series A | $20M | - |
Mentions in press and media 15
| Date | Title | Description | Source |
| 24.01.2023 | Apexigen Announces Approximately $2.8 Million Private Placem... | - | globenewsw... |
| 09.04.2021 | Apexigen Announces Presentations Of Preclinical Data For Its... | SAN CARLOS, Calif., April 9, 2021 /PRNewswire/ -- Apexigen, Inc., a clinical-stage biopharmaceutic... | prnewswire... |
| 09.11.2020 | Apexigen Announces First Preclinical Data Presentations On N... | SAN CARLOS, Calif., Nov. 9, 2020 /PRNewswire/ -- Apexigen, Inc., a clinical-stage biopharmaceutica... | prnewswire... |
| 24.03.2020 | Apexigen Closes $123M Series C Financing Round | Apexigen, Inc., a San Carlos, Calif.-based clinical-stage biopharmaceutical company focused on disco... | finsmes.co... |
| 24.03.2020 | Apexigen Completes $123 Million Series C Financing To Advanc... | - | 3ebiovc.co... |
| 24.03.2020 | Apexigen Pulls In $65M Series C Financing | SAN CARLOS, CA, Apexigen today announced the completion of a $65 million equity financing. >&g... | vcnewsdail... |
| 10.08.2018 | Term Sheet — Friday, August 10 | MORE DEBT Happy Friday, Term Sheet readers. Paid Content Securing the enterprise without boundarie... | fortune.co... |
| 09.08.2018 | Apexigen Secures $73M | SAN CARLOS, CA, Apexigen today announced the successful completion of its Series B and Series C fi... | vcnewsdail... |
| 08.08.2018 | Apexigen Raises $73M in Series B And Series C Financings | Apexigen, Inc., a San Carlos, Calif.-based clinical-stage biopharmaceutical company, completed its S... | finsmes.co... |
| 08.08.2013 | Apexigen Closes $20M Series A1 Financing | Apexigen, a Burlingame, Calif.-based biopharmaceutical company, closed $20m a Series A1 financing. ... | finsmes.co... |
Show more